The assay is fast and simple and has already shown clinical utility, although its interpretation may be limited by reference ...

The MHRA has approved Siiltibcy, a new skin test that uses recombinant proteins to more accurately detect tuberculosis in ...

More than a year and a half into Cullinan Therapeutics’ pivot from a CD19-focused oncology company to a hybrid autoimmune player, the biotech is parting ways with a pair of cancer programs. | More ...

Demonstrates PPARG inhibition as a potential strategy to overcome immune resistance in advanced UC− Supports the planned Phase 1 cohort of ...

Cellectricon broadens discovery capabilities with launch of Neurotoxicity Testing Services: Molndal, Sweden Saturday, November 1, 2025, 11:00 Hrs [IST] Cellectricon, a services pr ...

Presented new preclinical data on INB-619, a novel gamma-delta (γδ) T cell engager (TCE), demonstrating equivalent potency comparable to ...

It’s rich, creamy, melty, comforting—and we absolutely love cheese. Of course, we’d love to be lean and healthy too. Do we ...

The immune drugmaker is the second biotech, along with MapLight Therapeutics, to recently use a workaround in U.S. securities ...

Flatiron Health today announced its presence at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition happening from December 6-9, 2025, in Orlando, Florida. Flatiron's ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...